$13.85
-0.10[-0.72%]
At close: May 14
$14.17
0.3200[2.31%]
After Hours: 8:45AM EDT
Abivax Stock (NASDAQ:ABVX), Analyst Ratings, Price Targets, Predictions
Abivax SA has a consensus price target of $32, established from looking at the 5 latest analyst ratings. The last 3 analyst ratings were released from Guggenheim, Piper Sandler, and Morgan Stanley on April 29, 2024, April 29, 2024, and April 11, 2024. With an average price target of $36 between Guggenheim, Piper Sandler, and Morgan Stanley, there's an implied 159.93% upside for Abivax SA from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Guggenheim
Piper Sandler
Morgan Stanley
Leerink Partners
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Abivax
No data available to display
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|
FAQ
What is the target price for Abivax (ABVX)?
The latest price target for Abivax (NASDAQ: ABVX) was reported by Guggenheim on April 29, 2024. The analyst firm set a price target for $50.00 expecting ABVX to rise to within 12 months (a possible 261.01% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Abivax (ABVX)?
The latest analyst rating for Abivax (NASDAQ: ABVX) was provided by Guggenheim, and Abivax initiated their buy rating.
When was the last upgrade for Abivax (ABVX)?
There is no last upgrade for Abivax.
When was the last downgrade for Abivax (ABVX)?
There is no last downgrade for Abivax.
When is the next analyst rating going to be posted or updated for Abivax (ABVX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Abivax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Abivax was filed on April 29, 2024 so you should expect the next rating to be made available sometime around April 29, 2025.
Is the Analyst Rating Abivax (ABVX) correct?
While ratings are subjective and will change, the latest Abivax (ABVX) rating was a initiated with a price target of $0.00 to $50.00. The current price Abivax (ABVX) is trading at is $13.85, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.